ℹ️
🇬🇧
Search
Search for people relevant for "generators"
generators
Person
Class
Person
Publication
Programmes
Export current view
RNDr. Pavol Szabo Ph.D.
Academic staff at First Faculty of Medicine
50 publications
Publications
publication
Heterogeneous response to TGF-β1/3 isoforms in fibroblasts of different origins: implications for wound healing and tumorigenesis
2023 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Intercellular crosstalk in human malignant melanoma
2017 |
First Faculty of Medicine
publication
Extracellular Matrix of Galectin-1-exposed Dermal and Tumor-associated Fibroblasts Favors Growth of Human Umbilical Vein Endothelial Cells In Vitro: A Short Report
2014 |
First Faculty of Medicine
publication
Comparative Analysis of IL-8 and CXCL-1 Production by Normal and Cancer Stromal Fibroblasts
2013 |
First Faculty of Medicine
publication
Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors
2012 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Fibroblasts prepared from different types of malignant tumors stimulate expression of luminal marker keratin 8 in the EM-G3 breast cancer cell line
2012 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Human Galectins Induce Conversion of Dermal Fibroblasts into Myofibroblasts and Production of Extracellular Matrix: Potential Application in Tissue Engineering and Wound Repair
2011 |
First Faculty of Medicine
publication
Human Galectins Induce Conversion of Dermal Fibroblasts into Myofibroblasts and Production of Extracellular Matrix: Potential Application in Tissue Engineering and Wound Repair
2011 |
Second Faculty of Medicine
publication
Azulene hydrazido-hydrazones and their use for the treatment of oncological diseases
Publication without faculty affiliation
publication
Unravelling heterogeneous effects of cancer-associated fibroblasts on poor prognosis markers in breast cancer EM-G3 cell line: In vitro-targeted treatment (anti-IL-6, anti-VEGF-A, anti-MFGE8) based on transcriptomic profiling
2024 |
First Faculty of Medicine, Third Faculty of Medicine
Load more publications (40)
Loading network view...